Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Carcinoma, Merkel Cell
  • Dermatologic Conditions
  • Healthy Volunteers
  • Normal Volunteers
Type
Observational
Design
Observational Model: CohortTime Perspective: Prospective

Participation Requirements

Age
Between 2 years and 125 years
Gender
Both males and females

Description

Background: Skin diseases represent one of the most common medical problems in the-United States, affecting 1 in 3 people at any given time. Complex interactions between genetic background and the environment are-relevant to understanding skin disease. By studying dermatoses, we may gain insight int...

Background: Skin diseases represent one of the most common medical problems in the-United States, affecting 1 in 3 people at any given time. Complex interactions between genetic background and the environment are-relevant to understanding skin disease. By studying dermatoses, we may gain insight into the complex host environment-interactions that give rise to or exacerbate these skin-conditions, and into links between inflammation and cancer. Objective: -To procure biologic samples for exploratory cellular, molecular, genetic and genomic biological studies from subjects with dermatologic conditions, subjects at risk for developing dermatologic conditions and healthy volunteers in the support of NIH biomedical studies Eligibility: -Subjects with or at risk for developing dermatologic diseases, family members of subjects with dermatologic diseases, or healthy volunteers, including adults and children. Design: The purpose of this study is to examine, in an exploratory fashion, a variety of biologic assays relevant to the investigation of dermatologic diseases. Approximately 50 subjects are anticipated to consent to the study each year with an accrual ceiling of 500 consented subjects planned over 10 years.

Tracking Information

NCT #
NCT02471352
Collaborators
Not Provided
Investigators
Principal Investigator: Heidi H Kong, M.D. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)